Chemical activators of RPL39 engage in a series of interactions that result in the functional upregulation of this ribosomal protein's activity. Phorbol 12-myristate 13-acetate, for instance, activates protein kinase C (PKC), which is known to phosphorylate a variety of substrates, including ribosomal proteins, thereby enhancing their functionality in protein synthesis. Forskolin operates by elevating intracellular cAMP levels, which in turn activates PKA, another kinase that can phosphorylate RPL39, leading to an increase in its ribosomal activity. Similarly, ionomycin acts by increasing intracellular calcium concentrations, which triggers the activation of a cascade of calcium-dependent kinases. These kinases can also target RPL39, phosphorylating and activating it within the complex molecular machinery of the ribosome.
The role of protein phosphatases in the regulation of RPL39 cannot be understated, and several chemicals act by inhibiting these phosphatases, thereby ensuring RPL39 remains in a phosphorylated and active state. Okadaic Acid and Calyculin A both inhibit protein phosphatases such as PP1 and PP2A, which would otherwise dephosphorylate RPL39, leading to a decrease in its activity. Endothall and Cantharidin share a similar mechanism of action, inhibiting phosphatases and sustaining RPL39 in its active, phosphorylated form. Anisomycin activates stress-activated protein kinases which, upon activation, are known to phosphorylate various substrates, including those involved in ribosomal functions, like RPL39. Thapsigargin disrupts the calcium balance within the cell, leading to kinase activation that can result in the phosphorylation and consequent activation of RPL39. Lastly, Bisindolylmaleimide I and 4β-Phorbol, while primarily known for their interactions with PKC, can also ensure the activation of RPL39 through the kinase's phosphorylation activity. Mevalonolactone, through its role in the mevalonate pathway, can lead to biochemical modifications of proteins that interact with the ribosome, potentially resulting in the activation of RPL39 as these proteins carry out their roles in protein synthesis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which in turn can phosphorylate and thus activate RPL39 in its function within the ribosome. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Increases cAMP levels which activates PKA that can phosphorylate RPL39, leading to its activation in the ribosome. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Raises intracellular calcium levels, activating calcium-dependent kinases that can phosphorylate and activate RPL39. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, preventing dephosphorylation and maintaining RPL39 in an active state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $160.00 $750.00 | 59 | |
Similarly to Okadaic Acid, inhibits phosphatases leading to sustained phosphorylation and activation of RPL39. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $48.00 $199.00 | 1 | |
Inhibits protein phosphatases and can keep RPL39 phosphorylated, which is a state of activation for the protein. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $81.00 $260.00 | 6 | |
Inhibits serine/threonine protein phosphatases, leading to an active phosphorylated state of RPL39. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates stress-activated protein kinases that can phosphorylate and activate RPL39. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts calcium homeostasis, which can lead to the activation of kinases that phosphorylate and activate RPL39. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Specific inhibitor of PKC that in certain contexts can paradoxically lead to its activation and thereby the activation of RPL39. | ||||||